Treadmill exercise testing is the most common noninvasive test to assess patients with suspected or known cardiovascular...

A recent study in the European Heart Journal has found that vitamin D deficiency can increase the risk of cardiovascular...

According to a new study done by Wendy Zhou and colleagues, motility problems in postural orthostatic tachycardia...

Radiofrequency ablation for atrial fibrillation (AF) is an "economically attractive" option compared with drug therapy,...

Low-density lipoprotein (LDL) cholesterol, popularly known as bad cholesterol is major cause of heart disease. LDL C...

The CHIEF- HF trial results have shown that treating heart failure (HF) patients with canagliflozin a sodium-glucose...

Cardiovascular diseases are the leading cause of death globally. Though new medications and the use of effective...

Empagliflozin provides a wide range of benefits in patients with "true" heart failure and preserved ejection fraction...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are used to treat type 2 Diabetes Mellitus. GLP-1 RAs drugs are...

Patients with acute heart failure were safely started on empagliflozin a median of 3 days after hospitalization and were...

Bentracimab, an intravenous reversal agent for ticagrelor, has shown immediate and sustained reversal of the...

A new study conducted by Tomer Gazit and team showed that a mobile technology hypertension self-management tool can help...